Carriers of 21-Hydroxylase Deficiency Are Not at Increased Risk for Hyperandrogenism
February 1997
in “
The Journal of Clinical Endocrinology and Metabolism
”
Studysummary This study concluded that heterozygosity for CYP21 mutations is associated with higher mean and free testosterone levels in women but does not significantly increase their risk of developing clinically evident hyperandrogenism.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on academic.oup.com →